Literature DB >> 23122816

Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors.

Takashi Chiba1, Jun Ohwada, Hiroshi Sakamoto, Takamitsu Kobayashi, Takaaki A Fukami, Machiko Irie, Takaaki Miura, Kazuhiro Ohara, Hiroshi Koyano.   

Abstract

We conducted a high throughput screening for glyoxalase I (GLO1) inhibitors and identified 4,6-diphenyl-N-hydroxypyridone as a lead compound. Using a binding model of the lead and public X-ray coordinates of GLO1 enzymes complexed with glutathione analogues, we designed 4-(7-azaindole)-substituted 6-phenyl-N-hydroxypyridones. 7-Azaindole's 7-nitrogen was expected to interact with a water network, resulting in an interaction with the protein. We validated this inhibitor design by comparing its structure-activity relationship (SAR) with that of corresponding indole derivatives, by analyzing the binding mode with X-ray crystallography and by evaluating its thermodynamic binding parameters.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23122816     DOI: 10.1016/j.bmcl.2012.10.045

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Structural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor.

Authors:  Hong Zhang; Qiang Huang; Jing Zhai; Yi-ning Zhao; Li-ping Zhang; Yun-yun Chen; Ren-wei Zhang; Qing Li; Xiao-peng Hu
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

2.  A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.

Authors:  Seth M Cohen
Journal:  Acc Chem Res       Date:  2017-07-17       Impact factor: 22.384

3.  Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor.

Authors:  Christian Perez; Amanda M Barkley-Levenson; Benjamin L Dick; Peter F Glatt; Yadira Martinez; Dionicio Siegel; Jeremiah D Momper; Abraham A Palmer; Seth M Cohen
Journal:  J Med Chem       Date:  2019-01-31       Impact factor: 7.446

Review 4.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

5.  Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking.

Authors:  Nizar A Al-Shar'i; Qosay A Al-Balas; Rand A Al-Waqfi; Mohammad A Hassan; Amer E Alkhalifa; Nehad M Ayoub
Journal:  J Comput Aided Mol Des       Date:  2019-10-19       Impact factor: 3.686

Review 6.  Glo1 inhibitors for neuropsychiatric and anti-epileptic drug development.

Authors:  Katherine M J McMurray; Margaret G Distler; Preetpal S Sidhu; James M Cook; Leggy A Arnold; Abraham A Palmer; Leigh D Plant
Journal:  Biochem Soc Trans       Date:  2014-04       Impact factor: 5.407

7.  Salicylate metal-binding isosteres as fragments for metalloenzyme inhibition.

Authors:  Moritz K Jackl; Hyeonglim Seo; Johannes Karges; Mark Kalaj; Seth M Cohen
Journal:  Chem Sci       Date:  2022-01-21       Impact factor: 9.825

8.  Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors.

Authors:  Suaad Abdallah Audat; Qosay Ali Al-Balas; Buthina Abdallah Al-Oudat; Mo'ad Jamil Athamneh; Amanda Bryant-Friedrich
Journal:  Drug Des Devel Ther       Date:  2022-03-28       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.